Filing Details
- Accession Number:
- 0001127602-24-027317
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-14 18:38:10
- Reporting Period:
- 2024-11-13
- Accepted Time:
- 2024-11-14 18:38:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1326732 | Xencor Inc | XNCR | Pharmaceutical Preparations (2834) | 201622502 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1591312 | I Bassil Dahiyat | C/O Xencor, Inc. 465 N Halstead Street, Suite 200 Pasadena CA 91107 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-11-13 | 3,366 | $15.69 | 355,981 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-11-13 | 3,366 | $24.02 | 352,615 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-11-13 | 3,366 | $0.00 | 3,366 | $15.69 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 71,634 | 2025-02-11 | No | 4 | M | Direct |
Footnotes
- This transaction is pursuant to a 10b5-1 plan adopted by the Reporting Person on June 14, 2024.
- Includes the following shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan: 417 shares acquired on June 10, 2024.
- Includes 304 shares previously inadvertently omitted due to a clerical error. On March 6, 2024, the Reporting Person filed a Form 4 which reported that, following the transactions, the Reporting Person beneficially owned a total of 354,635 shares of Common Stock (the "Original Report"). The Original Report and the subsequent Form 4s filed by the Reporting Person on March 12, 2024 and July 1, 2024 inadvertently omitted 304 shares held by the Reporting Person due to a clerical error.
- Represents the disposition of shares sold to pay option cost and estimated tax liability due upon option exercise.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.07, inclusive. The Reporting Person undertakesto provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at eachseparate price within the ranges set forth in this footnote.
- 25% of the shares subject to the option vested on the one year anniversary of February 12, 2015 (the "Vesting Commencement Date"), and 1/48th of the shares vested monthly thereafter, such that the option was fully vested and exercisable on the four year anniversary of the Vesting Commencement Date.
- The Reporting Person previously transferred 75,000 shares underlying the stock option to his ex-spouse. The Reporting Person no longer reports as beneficially owned any securities owned by his ex-spouse.
Billionaire Hedge Funds
